More about Aether Industries Limited
Fundamentals for Aether Industries Limited
Regulatory Filings for Aether Industries Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Aether Industries Limited
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Aether Industries Limited produces and sells advanced intermediates and specialty chemicals in India and internationally. The company offers 4-(2-Methoxyethyl) phenol, 3-Methoxy-2-Methylbenzoyl Chloride, Thiophene-2-ethanol, Ortho Tolyl Benzo Nitrile / 4'-Methyl-2-Cyanobiphynyl, N-Octyl-D-glucamine/1- deoxy-1-(Octylamino)-D-Glucitol, 1-2-(2Hydroxyethoxy) Ethyl Piperazine, Delta-Valerolactone, and bifenthrin alcohol products. It also provides contract research and manufacturing services, as well as contract/exclusive manufacturing services. The company serves its products to pharmaceutical, agrochemical, material science, high performance photography, additives, and oil and gas industries. Aether Industries Limited was incorporated in 2013 and is headquartered in Surat, India.
Revenue projections:
AETHER's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 52.105705 |
| debtToEquity | 9.242000 |
| earningsGrowth | 0.486000 |
| revenueGrowth | 0.444000 |
| grossMargins | 0.491840 |
| operatingMargins | 0.294290 |
| trailingEps | 16.290000 |
| forwardEps | 22.538800 |
Aether Industries Limited's forward PE is too high, potentially limiting future gains and posing a risk of a price correction. This valuation must be carefully considered with other fundamental metrics to evaluate whether the stock is worth its current price.
AETHER's positive earnings and revenue growth signal that the company is expected to expand its business. The company's increasing profits and sales reflect strong financial health, suggesting continued growth and success in the coming periods.
With positive gross and operating margins, AETHER's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.
With a forward EPS greater than its trailing EPS, Aether Industries Limited is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.
Price projections:
Price projections for Aether Industries Limited have been revised upward over time, signaling increasing optimism about the company's future. This steady increase reflects a positive outlook for Aether Industries Limited's growth and market performance.
Insider Transactions:
There were 1 transactions selling Aether Industries Limited stock, with prevailing market price of 748.8499755859375.No sell transactions were carried out during the period under review.More buys than sells near the current price levels of AETHER might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.
Recommendation changes over time:
The analysts' recent buy bias for Aether Industries Limited indicates strong confidence in the stock's future performance. This could encourage more investors to view Aether Industries Limited as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy